BNP Paribas Financial Markets’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.14M | Buy |
|
|||||
|
2025
Q2 | $470K | Sell |
|
|||||
|
2025
Q1 | $4.14M | Sell |
|
|||||
|
2024
Q4 | $4.18M | Sell |
|
|||||
|
2024
Q3 | $5.96M | Buy |
|
|||||
|
2024
Q2 | $3.06M | Buy |
|
|||||
|
2024
Q1 | $2.57M | Buy |
|
|||||
|
2023
Q4 | $2.92M | Sell |
|
|||||
|
2023
Q3 | $3.14M | Sell |
|
|||||
|
2023
Q2 | $4.47M | Buy |
|
|||||
|
2023
Q1 | $1.29M | Buy |
|
|||||
|
2022
Q4 | $447K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $711K | Sell |
|
|||||
|
2022
Q1 | $1.45M | Sell |
|
|||||
|
2021
Q4 | $1.77M | Sell |
|
|||||
|
2021
Q3 | $2.39M | Buy |
|
|||||
|
2021
Q2 | $938K | Buy |
|
|||||
|
2021
Q1 | $602K | Sell |
|
|||||
|
2020
Q4 | $579K | Sell |
|
|||||
|
2020
Q3 | $681K | Buy |
|
|||||
|
2020
Q2 | $187K | Sell |
|
|||||
|
2020
Q1 | $6.54M | Buy |
|
|||||
|
2019
Q4 | $461K | Buy |
|
|||||
|
2019
Q3 | $278K | Buy |
|
|||||
|
2019
Q2 | $233K | Sell |
|
|||||
|
2019
Q1 | $352K | Buy |
|
|||||
|
2018
Q4 | $41.3K | Sell |
|
|||||
|
2018
Q3 | $112K | Buy |
|
|||||
|
2018
Q2 | $67.1K | Sell |
|
|||||
|
2018
Q1 | $269K | Buy |
|
|||||
|
2017
Q4 | $377K | Buy |
|
|||||
|
2017
Q3 | $179K | Sell |
|
|||||
|
2017
Q2 | $239K | Buy |
|
|||||
|
2017
Q1 | $33.6K | Sell |
|
|||||
|
2016
Q4 | $37.7K | Sell |
|
|||||
|
2016
Q3 | $104K | Buy |
|
|||||
|
2016
Q2 | $48.7K | Buy |
|
|||||
|
2016
Q1 | $1.43K | Sell |
|
|||||
|
2015
Q4 | $543K | Sell |
|
|||||
|
2015
Q3 | $308K | Buy |
|
|||||
|
2015
Q2 | $214K | Buy |
|
|||||
|
2015
Q1 | $75.7K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $203K | Buy |
|
|||||
|
2014
Q2 | $5.51K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $20.5K | Sell |
|
|||||
|
2013
Q3 | $363K | Sell |
|
|||||
|
2013
Q2 | $283K | Buy |
|